Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
about
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisNon-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosisNonabsorbable disaccharides for hepatic encephalopathyGastrointestinal effects of low-digestible carbohydratesMeta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy.Treatment options for hepatic encephalopathy.Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver.Disaccharides in the treatment of hepatic encephalopathy.Management of covert hepatic encephalopathy.Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis.Hepatic encephalopathy: what the multidisciplinary team can do.Management of hepatic encephalopathy by traditional chinese medicine.Rifaximin for the treatment of hepatic encephalopathy.Effect of protein and lactulose on the production of gamma-aminobutyric acid by faecal Escherichia coli.Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters.The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal SystemPortosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations
P2860
Q24185782-36E2A540-AC75-4E35-B66E-9C31AFFD945FQ24185895-7115E669-A98E-4B1C-8391-654607F4FC24Q24247141-8D3070D8-5D1F-4984-AB30-1C22ABD46FC5Q28235996-63CE8129-EE9B-4E17-A0BF-F1A8E4C5FC6AQ34160004-217F73E2-1F34-4BC0-B057-5903B842C159Q37735854-BC66A2D8-5E68-4D94-A230-3E75631262D3Q37769273-F444EEE1-095E-42DA-B57C-ED6F5257832CQ38086120-724C0E4C-BE69-4BFB-80F4-5F1853FE876BQ38515281-B6927549-E93F-4574-9E38-63AE15AD5336Q38809023-C5D14A8D-F9E1-4FA2-9A1B-65919050A51AQ39230493-7AF16297-7096-4947-869B-EA35C4DA57CDQ39620126-A603FF50-7A22-4BCD-8404-122A475CD2B3Q42792218-E7882E4B-8E3D-4503-98F5-DA10F3E199CCQ43220595-C86A739B-F7D4-4B16-BDC6-4011B4A8242EQ46478383-DAB5ADDF-7F03-43B8-A74A-0BCC7365B14DQ46516835-CDB0457D-EECE-4D47-9684-E6BB1319B315Q48783655-BFE60F50-5B31-4116-A653-F5174985DE94Q57825805-47E14023-770E-476B-8D16-43D4EAE385B5Q58478305-73C4113B-C954-4016-94D7-008537763605
P2860
Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Lactitol and lactulose for the ...... randomised, cross-over study.
@ast
Lactitol and lactulose for the ...... randomised, cross-over study.
@en
type
label
Lactitol and lactulose for the ...... randomised, cross-over study.
@ast
Lactitol and lactulose for the ...... randomised, cross-over study.
@en
prefLabel
Lactitol and lactulose for the ...... randomised, cross-over study.
@ast
Lactitol and lactulose for the ...... randomised, cross-over study.
@en
P2093
P1476
Lactitol and lactulose for the ...... randomised, cross-over study.
@en
P2093
P304
P356
10.1016/0168-8278(89)90009-3
P577
1989-03-01T00:00:00Z